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Abstract Bv8, a protein from skin secretions of Bombina
variegata, reacts with receptors present in mammalian brain and
intestine (Mollay et al. (1999) Eur. J. Pharmacol. 374, 189^196).
As deduced from cloned cDNAs, the murine and human Bv8
homologues have identical amino-terminal sequences and also
contain 10 cysteines. From mouse testes, two forms of Bv8
mRNA have been characterized, of which one contains an
additional exon which codes for 21 mostly basic amino acids. The
mouse Bv8 gene is most active in mid-late pachytene spermato-
cytes. In mouse testes, Bv8 mRNA can first be detected at the
end of the second week post partum.
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1. Introduction
Work over the past three decades has demonstrated that
amphibian skin produces numerous biologically active pep-
tides [1,2]. Many of these are related to mammalian hormones
and/or neurotransmitters. In continuation of our work on the
constituents present in skin secretions from two Bombina spe-
cies [3^5], we have recently isolated a small protein which we
termed Bv8 [6]. This name indicates its origin, the skin secre-
tion of Bombina variegata, as well as its molecular mass of
about 8 kDa. Bv8 is related to protein A, a non-toxic con-
stituent of the venom of the black mamba [7]. Both proteins
are distantly related to mammalian co-lipases [8]. Evidence
has been presented that the pattern of disul¢de bridges is in-
deed the same in protein A and co-lipase [9].
Pharmacological tests have demonstrated that receptors for
Bv8 and protein A are present in mammalian tissues [6]. Both
proteins stimulate the contraction of the guinea pig ileum at
nanomolar concentrations. In addition, a few minutes after
injection into the brain of rats, the animals develop hyper-
algesia as assessed by the tail £ick and paw pressure test.
These observations suggest that homologues of Bv8 also exist
in mammals.
In this communication, we present the structure of Bv8
precursors from mouse brain and testes and from human
testes as deduced from cloned cDNAs. In addition, we present
evidence for the cell and stage-speci¢c expression of the Bv8
gene in meiotic germ cells.
2. Materials and methods
2.1. mRNA isolation, reverse-transcriptase PCR and isolation of cDNA
clones
Isolation of RNA, synthesis of cDNA and RACE were carried out
as described earlier [6]. RACE-PCR ampli¢cations were performed
using sense (CCG AGA CAG GGG GTG GCA GCT G) and anti-
sense primers (CTT GCG ACA AGG ACT CTC AGT GCG G) as
derived from the sequence of a 126 bp exon isolated from mouse
embryonic stem cells [10] which is very similar to the region of nu-
cleotides 142 to 267 of the cDNA clone encoding Bv8 from Bombina
skin. Vgt [11] cDNA libraries from mouse (Stratagene) and human
testis (Clontech) were screened using standard procedures. Nucleotide
sequences were deposited in the GenBank data bank.
For the analysis of alternatively spliced transcripts, primers were
designed which bind sequences on three di¡erent exons: exon2-for-
ward: AGC TGC CAC CCC CTG ACT CG, exon3-forward: CAA
ATG GAA GGC AGG AAA GAA G and exon4-reverse: TTC CGG
GCC AAG CAA ATA AAC C. RT-PCR was performed using
‘Ready To Start’ reagents from Amersham-Pharmacia Biotech.
2.2. Northern blots and in situ hybridization
Twenty Wg of total RNA from di¡erent mouse tissues as well as
from spermatocytes, spermatids, Sertoli and Leydig cells were used for
Northern analysis. As probes, the radiolabeled mouse brain or testis
cDNA were hybridized overnight under high stringency conditions as
described [6].
Mouse brain Bv8 cDNA subcloned into plasmid Bluescript KS II
was linearized and antisense and sense probes labeled with [35S]UTP
were synthesized using T3 or T7 RNA polymerase (Promega, Madi-
son, WI, USA). The in situ hybridization protocol has been described
previously [12].
2.3. Cell preparation
Germ cells form testis of CD1 mice were separated as described
before [12]. The cell fractions composed of 85^90% of mid-late pachy-
tene spermatocytes and round spermatids were collected. Total RNA
was prepared and used for Northern blotting. Sertoli cells were iso-
lated as described by Risbridger et al. [13]. In order to remove con-
taminating germ cells, hypotonic treatment was performed at day 3 of
culture [14].
3. Results
3.1. Isolation of cDNAs encoding mammalian Bv8 homologues
From total RNA isolated from mouse brain, a Bv8 cDNA
could be ampli¢ed using the 3P-and 5P-RACE protocols. Start-
ing from the ¢rst ATG codon, this cDNA contains an open
reading frame potentially encoding a polypeptide of 86 amino
acids. Of these, the ¢rst 26 have the typical features of a signal
peptide. The following sequence of 47 residues is closely re-
lated to the corresponding part of frog Bv8 (62% identity).
To search for tissues where this mRNA might be present in
higher abundance than in brain, Northern blots were per-
formed (see Fig. 3). As shown below, a strong signal was
obtained with RNA from testis. With the cDNA ampli¢ed
0014-5793 / 99 / $20.00 ß 1999 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 1 4 7 3 - 8
*Corresponding author. Fax: +43-662-639-6129.
E-mail: gkreil@oeaw.ac.at
FEBS 22907 18-11-99
FEBS 22907 FEBS Letters 462 (1999) 177^181
from mouse brain we then screened cDNA libraries from
mouse and from human testis. From the former, a clone
was isolated containing an insert of 1429 bp, excluding the
poly(A) tail. It contains an open reading frame encoding a
polypeptide of 121 amino acids (Fig. 1). In addition, a shorter
version was cloned by PCR using primers speci¢c for the
sequences covering the start and stop codons of Bv8. The
long form termed Bv8-b (basic) contains an insert of 21 amino
acids (see Fig. 1B), of which 11 are lysines or arginines. As
these occur in two clusters, it seems likely that some proteo-
lytic cleavage takes place as these molecules cross the secre-
tory pathway. The shorter variant was termed Bv8-a as it
resembles the amphibian Bv8 more closely. A closely related
cDNA was isolated from a human testes cDNA library.
A comparison of the amino acid sequences of the mouse,
human, and Bombina Bv8 precursors is shown in Fig. 2. The
mouse and human precursors are very similar, both with re-
spect to their signal peptide and the mature region. In partic-
ular, they all contain 10 cysteines with similar spacing and
frequently also identical neighboring residues. The most strik-
ing feature is the highly conserved N-terminal sequence
AVITGACDKDS(V)QCG. This suggests that this part is cru-
cially important for the biological function of these polypep-
tides.
Fig. 1. cDNA and deduced protein sequences of mouse Bv8. A: Schematic drawing of Bv8-a and -b. B: Full length cDNA sequence of Bv8-a
and -b (in box) upper lane together with the translation product. The alternatively used exon junctions are highlighted, the signal sequence
cleavage site is indicated by a double slash and the stop codon is marked (*).
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3.2. Tissue distribution of Bv8 gene expression
Northern blots with RNA from di¡erent mouse tissues
yielded a strong signal in testis, while a faint band was present
in all the others (see Fig. 3A). Therefore, RNA from various
tissues was used as a template for RT-PCR in the presence of
exon-speci¢c primers. Bv8-a is expressed by all tissues tested,
whereas Bv8-b mRNA only could be detected unambiguously
in testis (Fig. 3B). This indicates alternative splicing of the Bv8
transcript in this organ.
We also tested the expression of the Bv8 gene during mouse
testicular development. The Bv8 transcript could barely be
detected at the end of the second week, while a strong signal
was observed from 3 weeks onwards (Fig. 3C). The Bv8
mRNA could not be detected in testis of mice with the Tfm
mutation.
3.3. Characterization of Bv8 expressing cells in testis
We used in situ hybridization to investigate the localization
of the Bv8 mRNA in testis. In adult mouse testis, a strong
signal was observed in the tubules (Fig. 4A and C) in a region
which roughly corresponds to the area occupied by meiotic
cells. A closer analysis revealed that Bv8 mRNA was localized
in mid-late pachytene spermatocytes at the stages VII, VIII
and IX of the seminiferous epithelial cycle (Fig. 4C). No spe-
ci¢c signal was present in the interstitium.
The expression of Bv8 mRNA in mouse testis was also
investigated using highly puri¢ed populations of both germ
and somatic cells. The 1.8 kb Bv8 transcript is present in
pachytene spermatocytes, whereas expression is low in round
spermatids (Fig. 5). Sertoli cells as well as Leydig cells (data
not shown) did not yield a signal. This result is in good agree-
ment with the in situ data.
4. Discussion
I.c.v. injection of Bv8 from frog skin or protein A from the
venom of the black mamba causes hyperalgesia [6]. We there-
fore searched for mRNAs encoding mammalian homologues
of Bv8 in brain. From mouse brain, a partially spliced cDNA
could be isolated. We know from partial sequences of the
mouse Bv8 gene that the last 418 bases of this cDNA are
derived from an intron (unpublished experiments). cDNAs
containing the complete coding information for Bv8 could
be isolated from mouse and human testis. The size of these
mRNAs closely corresponds to the 1.8 kb signal seen on
Northern blots. From mouse testis, two variants were charac-
terized which code for a longer form termed Bv8-b and a
shorter one, Bv8-a. The former contains an insert of 21 amino
acids. The two clusters of lysine/arginine residues present in
this insert are potential cleavage sites for furin or other pro-
hormone convertases [15], in particular for the testis-speci¢c
PC4 enzyme [16]. This would yield a two-chain form of Bv8
with possibly di¡erent biological activities. On the Northern
blot with testis mRNA, a second weaker signal was present at
about 0.8 kb which may code for yet another variant of Bv8.
Small amounts of Bv8 mRNA are present in all other tis-
sues tested. However, with RT-PCR only the mRNA encod-
ing the shorter Bv8-a variant could be detected.
In testis, the expression of the Bv8 gene is regulated in a
temporal and spatial manner during spermatogenesis. The in
situ hybridization data indicate that Bv8 is expressed predom-
Fig. 2. Sequence of Bv8 from di¡erent species. A: Mouse Bv8, com-
plete precursor assembled as shown in Fig. 1. B: Partial sequence
of the human Bv8 precursor deduced from a cloned cDNA. C: Bv8
precursor from skin of Bombina variegata [6]. The mature frog pro-
tein starts with the sequence AVITT. Bv8-b proteins contain an in-
sert of 21 residues, which is marked by dots in the Bombina se-
quence. Identities between the three proteins are marked (*).
Fig. 3. Northern blot experiments. A: RNA from di¡erent mouse
tissues probed with the cloned Bv8 cDNA from mouse brain. Expo-
sure time: 2 days. B: RT-PCR using speci¢c primers for Bv8-a or
-b and mRNA from various tissues as indicated. C: RNA from
mouse testis 2, 3, 4, 5, 6 and 8 weeks after birth. T, testis from
mice with the Tfm mutation; 0, control lane without RNA. Expo-
sure time: 3 days. Lower panel: 28S and 18S RNA from same blot
visualized with ethidium bromide.
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inantly in mid-late pachytene spermatocytes during the stages
VII^IX of the seminiferous epithelium cycle. These data are in
agreement with the Northern blot analysis of RNA extracted
from pachytene spermatocytes which were highly puri¢ed by
sedimentation at unit gravity. In addition, in mouse testis,
only small amounts of the Bv8 mRNA could be detected at
2 weeks after birth, whereas its level greatly increases at
3 weeks and from then on persists at high level. This all is
also in line with the ¢nding that Bv8 mRNA is absent in
the testis of mice bearing the Tfm mutation [17]. XY males
with the Tfm mutation on their X chromosome do not re-
spond to testosterone and thus di¡erentiation of germ is
blocked at early spermatocyte stages.
The expression pattern of Bv8 after birth correlates well
with the maturation of mouse testis. In particular, at postna-
tal day 17 the most advanced germ cells in seminiferous tu-
bules are at the mid-pachytene stage in a ¢rst wave of sper-
matogenesis. By day 22, the meiotic divisions have been
completed in some tubules, whereas in the most others late
pachytene and diplotene spermatocytes are present. More-
over, we found that homogeneous populations of isolated
round spermatids (haploid cells) contain very low levels of
Bv8 transcripts. In line with this, in situ mRNA hybridization
revealed only low levels of Bv8 transcripts in areas of the
tubules where round spermatids are located.
At stages VII and VIII, two major events occur: the last
DNA duplication prior to the meiotic divisions and spermia-
tion. Bv8 could possibly function as an autocrine or paracrine
signaling molecule in these cellular processes. The secretory
activity and morphology of Sertoli cells is in fact dependent
upon the stage of neighboring germ cells [18]. So it is conceiv-
able that speci¢c factors, like Bv8, that are released from germ
cells are important in this context. However, it is also possible
that the Bv8 protein is stored in spermatocytes and functions
only later in mature spermatozoa.
Our results demonstrate that homologues of frog skin Bv8
and protein A from snake venom exist in mammals. We have
started to construct Bv8 knockout mice to investigate the role
of this protein in testes and other organs.
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